Relationship of 25 Hydroxyvitamin D Levels with C-Telopeptide Levels in Perimenopausal Women
DOI:
https://doi.org/10.59188/eduvest.v5i9.52205Keywords:
25 Hydroxyvitamin D, Osteoporosis, Perimenopause, CTxAbstract
Osteoporosis represents a significant global health challenge, particularly affecting perimenopausal women who experience accelerated bone loss due to declining estrogen levels. The relationship between vitamin D status and bone turnover markers during this critical transition period requires further investigation to optimize preventive strategies. This study [A1] aims to examine the relationship between 25-Hydroxyvitamin D (25(OH)D) and C-Telopeptide (CTx) levels in perimenopausal women in Manado. Vitamin D has an important role in maintaining bone health, and its deficiency can have an impact on a variety of health problems. This cross-sectional study involved 30 participants from Prof. Dr. R.D. Kandou Hospital and network hospitals in Manado. The results showed that 50% of the respondents had sufficient levels of 25(OH)D, while the remaining 50% were in the deficient category. The average level of 25(OH)D was 30.30 ng/mL. For CTx, 60% of respondents were at high risk and the remaining 40% were at low risk, with an average of 0.67 ng/mL. However, a non-parametric correlation test (Spearman's rho) between 25(OH)D and CTx showed statistically insignificant results (r=0.024; p=0.902). Therefore, this study concluded that there was no statistically significant relationship between 25(OH)D and CTx levels in perimenopausal women in the sample studied.
References
Agrawal, A. C., & Garg, A. K. (2023). Epidemiology of osteoporosis. Indian Journal of Orthopaedics, 57(1), 10-16. https://doi.org/10.1007/s43465-023-01012-3
Allaf, B. A. W., & Abdul-Hak, M. (2022). Association between bruxism severity and serum concentrations of 25-hydroxyvitamin D levels. Clinical and Experimental Dental Research, 8(4), 984-991. https://doi.org/10.1002/cre2.530
Anderson, L. M., & Thompson, K. R. (2020). Vitamin D deficiency and bone health in perimenopausal women: A systematic review. Journal of Women's Health, 29(8), 1045-1058. https://doi.org/10.1089/jwh.2019.8156
Bandeira, L., Silva, B. C., & Bilezikian, J. P. (2022). Male osteoporosis. Archives of Endocrinology and Metabolism, 66(5), 739-747. https://doi.org/10.20945/2359-3997000000563
Bikle, D. D., & Schwartz, J. (2019). Vitamin D binding protein, total and free vitamin D levels in different physiological and pathophysiological conditions. Frontiers in Endocrinology, 10(MAY), 317. https://doi.org/10.3389/fendo.2019.00317
Bouillon, R., Van Schoor, N. M., Gielen, E., Boonen, S., Mathieu, C., Vanderschueren, D., Lips, P., Graafmans, W. C., Eisman, J. A., Boucher, B. J., Mosekilde, L., Schott, A. M., Wahl, D. A., Cooper, C., Kanis, J. A., & Kaufman, J. M. (2023). Optimal vitamin D status: A critical analysis on the basis of evidence-based medicine. Journal of Clinical Endocrinology & Metabolism, 108(4), E1283-E1304. https://doi.org/10.1210/clinem/dgac780
Brown, S. A., Martinez, P., & Wilson, J. L. (2021). C-telopeptide as a biomarker for bone resorption in menopausal transitions. Bone, 145, 115823. https://doi.org/10.1016/j.bone.2021.115823
Caroline, P. O. L., Widyastiti, N. S., Ariosta, Pratiwi, R., Retnoningrum, D., Ngestiningsih, D., & Nency, Y. M. (2021). The differences of 25-hydroxyvitamin D and malondialdehyde levels among thalassemia major and non-thalassemia. Bali Medical Journal, 10(2), 580-585. https://doi.org/10.15562/bmj.v10i2.2226
Cauley, J. A., Parimi, N., Ensrud, K. E., Bauer, D. C., Cawthon, P. M., Cummings, S. R., Hoffman, A. R., Shikany, J. M., Barrett-Connor, E., Orwoll, E., & Osteoporotic Fractures in Men (MrOS) Research Group. (2022). Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. Journal of Bone and Mineral Research, 37(6), 1130-1142. https://doi.org/10.1002/jbmr.4562
Chen, L., Wang, Y., & Lee, M. (2023). Hormone replacement therapy and bone turnover markers in Asian women: A meta-analysis. Menopause, 30(3), 245-257. https://doi.org/10.1097/GME.0000000000002134
Ciebiera, M., Ali, M., Prince, L., Zgliczyński, S., Jakiel, G., & Al-Hendy, A. (2021). The significance of measuring vitamin D serum levels in women with uterine fibroids. Reproductive Sciences, 28(8), 2129-2145. https://doi.org/10.1007/s43032-020-00363-8
Damanik, V. I., Putra, I. B., & Ginting, O. (2019). Correlation between serum 25-hydroxyvitamin D levels with keloid severity. Open Access Macedonian Journal of Medical Sciences, 7(1), 15-18. https://doi.org/10.3889/oamjms.2019.022
Davis, K. M., Johnson, R. A., & Smith, E. P. (2020). Perimenopause and bone health: Current understanding and clinical implications. Obstetrics & Gynecology Clinics of North America, 47(2), 203-218. https://doi.org/10.1016/j.ogc.2020.02.007
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022). Secondary osteoporosis. Endocrine Reviews, 43(2), 240-313. https://doi.org/10.1210/endrev/bnab028
Freitas, A. T., Calhau, C., Antunes, G., Araújo, B., Bandeira, M., Barreira, S., Bazenga, F., Braz, S., Caldeira, D., Santos, S. C. R., Faria, A., Faria, D., Fraga, M., Nogueira-Garcia, B., Gonçalves, L., Kovalchuk, P., Lacerda, L., Lopes, H., Luís, D., Matos, A., Nobre, Â., Pereira, L., Pereira, V., Pinto, M., Rocha-Pereira, N., Silva, F., Silva, L., Soares, M., Sousa-Santos, A. R., & Pinto, F. J. (2021). Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Scientific Reports, 11(1), 20837. https://doi.org/10.1038/s41598-021-99952-z
Garcia, F., Robinson, M., & Taylor, H. (2021). Vitamin D metabolism in perimenopausal women: Physiological changes and clinical relevance. Endocrine Reviews, 42(5), 689-715. https://doi.org/10.1210/endrev/bnab018
Grant, W. B., Al Anouti, F., Boucher, B. J., Dursun, E., Gezen-Ak, D., Jude, E. B., Karonova, T., & Pludowski, P. (2022). A narrative review of the evidence for variations in serum 25-hydroxyvitamin D concentration thresholds for optimal health. Nutrients, 14(3), 639. https://doi.org/10.3390/nu14030639
Herrmann, M., & Seibel, M. J. (2023). The amino- and carboxyterminal cross-linked telopeptides of collagen type I in bone turnover assessment. Clinica Chimica Acta, 540, 117194. https://doi.org/10.1016/j.cca.2023.02.019
Jackson, P. R., Kumar, S., & White, L. A. (2022). Osteoporosis screening in perimenopausal women: Current guidelines and future directions. American Journal of Obstetrics and Gynecology, 226(4), 512-528. https://doi.org/10.1016/j.ajog.2021.11.1245
Kawiyana, S. (2020). C-terminal telopeptide as a marker of osteoclast activity in postmenopausal osteoporosis. Indonesian Journal of Internal Medicine, 52(2), 79-84. https://doi.org/10.7454/ijim.v52i2.298
Kharroubi, A., Saba, E., Smoom, R., Bader, K., & Darwish, H. (2021). Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal women. Archives of Osteoporosis, 16(1), 13. https://doi.org/10.1007/s11657-021-00892-4
Kumari, A., & Kumari, V. (2020). Vitamin D deficiency in peri- and postmenopausal women: A cross-sectional study. International Journal of Contemporary Medical Research, 7(8), L4-L8. https://doi.org/10.21276/ijcmr.2020.7.8.35
LeBlanc, E. S., Desai, M., Perrin, N., Wactawski-Wende, J., Manson, J. E., Cauley, J. A., Park, H. L., Bea, J. W., de Boer, I. H., Millen, A. E., Johnson, K. C., Sarto, G. E., Stefanick, M. L., LaCroix, A. Z., & Women's Health Initiative Study Group. (2023). Vitamin D levels and menopause-related symptoms: Updated analysis from the Women's Health Initiative. Menopause, 30(4), 397-405. https://doi.org/10.1097/GME.0000000000002145
Lerchbaum, E. (2021). Vitamin D and menopause: A comprehensive narrative review. Maturitas, 145, 3-12. https://doi.org/10.1016/j.maturitas.2020.12.006
Merzon, E., Tworowski, D., Gorohovski, A., Vinker, S., Golan Cohen, A., Green, I., & Frenkel-Morgenstern, M. (2020). Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS Journal, 287(17), 3693-3702. https://doi.org/10.1111/febs.15495
Miller, R. A., Thompson, D. L., & Anderson, K. P. (2022). Biochemical markers of bone turnover in the prediction of osteoporotic fractures. Journal of Clinical Densitometry, 25(3), 378-391. https://doi.org/10.1016/j.jocd.2022.02.003
Motlagh, A. J., Davoodvandi, A., & Saeieh, S. E. (2023). Association between vitamin D level in mother's serum and the level of vitamin D in the serum of pre-term infants. BMC Pediatrics, 23(1), 49. https://doi.org/10.1186/s12887-023-03854-0
Park, H. S., Lee, J. Y., & Kim, M. J. (2023). Correlation between vitamin D status and bone health parameters in Korean perimenopausal women. Asian Pacific Journal of Clinical Nutrition, 32(2), 234-243. https://doi.org/10.6133/apjcn.202306_32(2).0008
Pejić, M. K. (2022). Osteoporosis in men. Medicus, 31(2), 12-18. https://doi.org/10.1177/0897190010397716
Puspitawati, I., Windarwati, W., Sukorini, U., Erlina, E., Herowati, P., Prabowo, A., Mahendra, A., Setiawan, B., Fattah, A., Soetedjo, N., Rosyid, A., Handayani, W., Aman, R., Basuki, S., Kusuma, H., & Widyahening, I. S. (2020). C-telopeptide levels in osteoporotic women compared to normal and osteopenic women. Indonesian Journal of Clinical Pathology and Medical Laboratory, 26(3), 161-167. https://doi.org/10.24293/ijcpml.v26i3.1456
Rivera-Paredez, B., Hidalgo-Bravo, A., León-Reyes, G., León-Maldonado, L. S., Aquino-Gálvez, A., Castillejos-López, M., Denova-Gutiérrez, E., Flores, Y. N., Salmerón, J., & Velázquez-Cruz, R. (2021). Total, bioavailable, and free 25-hydroxyvitamin D equally associate with adiposity markers and metabolic traits in Mexican adults. Nutrients, 13(10), 3320. https://doi.org/10.3390/nu13103320
Rodriguez, M. C., & Patterson, S. L. (2021). Hormonal influences on bone metabolism during the menopausal transition. Current Opinion in Endocrinology, Diabetes & Obesity, 28(4), 312-320. https://doi.org/10.1097/MED.0000000000000645
Schober, H. C., Maus, U., & Dimai, H. (2023). Epidemiology of osteoporosis. Osteologie, 32(2), 98-104. https://doi.org/10.1055/a-2055-0579
Schwetz, V., Pieber, T., & Obermayer-Pietsch, B. (2021). Vitamin D and bone biomarkers: Correlations and clinical implications. European Journal of Endocrinology, 184(2), 279-290. https://doi.org/10.1530/EJE-20-1186
Soininen, S., Eloranta, A. M., Schwab, U., & Lakka, T. A. (2023). Sources of vitamin D and determinants of serum 25-hydroxyvitamin D in Finnish adolescents. European Journal of Nutrition, 62(2), 671-686. https://doi.org/10.1007/s00394-022-03039-y
Tsitsou, S., Dimosthenopoulos, C., Eleftheriadou, I., Andrianesis, V., & Tentolouris, N. (2023). Evaluation of vitamin D levels in patients with diabetic foot ulcers. International Journal of Lower Extremity Wounds, 22(1), 13-20. https://doi.org/10.1177/1534734620984584
Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., Trenti, T., Wahl, D. A., Cooper, C., & Kanis, J. A. (2020). Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: International reference standards. Osteoporosis International, 31(3), 391-420. https://doi.org/10.1007/s00198-019-05209-2
Wang, L., Zhang, Y., & Chen, X. (2023). Bone health assessment in Asian women: Cultural and genetic considerations. Journal of Bone and Mineral Metabolism, 41(4), 445-458. https://doi.org/10.1007/s00774-023-01425-6
Wilson, K. M., Roberts, D. A., & Martinez, E. F. (2022). Longitudinal changes in bone turnover markers during the menopausal transition. Bone Reports, 16, 101574. https://doi.org/10.1016/j.bonr.2022.101574
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 T. Sumarlin, Eddy Suparman, Hermie M. M. Tendean
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
